These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27496950)

  • 21. A rare cause of congenital adrenal hyperplasia: Antley-Bixler syndrome due to POR deficiency.
    Herkert JC; Blaauwwiekel EE; Hoek A; Veenstra-Knol HE; Kema IP; Arlt W; Kerstens MN
    Neth J Med; 2011 Jun; 69(6):281-3. PubMed ID: 21868813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
    Sandee D; Morrissey K; Agrawal V; Tam HK; Kramer MA; Tracy TS; Giacomini KM; Miller WL
    Pharmacogenet Genomics; 2010 Nov; 20(11):677-86. PubMed ID: 20940534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
    Flück CE; Nicolo C; Pandey AV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of POR mutations and polymorphisms.
    Miller WL; Agrawal V; Sandee D; Tee MK; Huang N; Choi JH; Morrissey K; Giacomini KM
    Mol Cell Endocrinol; 2011 Apr; 336(1-2):174-9. PubMed ID: 21070833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NADPH P450 oxidoreductase: structure, function, and pathology of diseases.
    Pandey AV; Flück CE
    Pharmacol Ther; 2013 May; 138(2):229-54. PubMed ID: 23353702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Antley-Bixler syndrome caused by compound heterozygous mutations of the cytochrome P450 oxidoreductase gene.
    Ko JM; Cheon CK; Kim GH; Yoo HW
    Eur J Pediatr; 2009 Jul; 168(7):877-80. PubMed ID: 18853185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.
    Marohnic CC; Panda SP; Martásek P; Masters BS
    J Biol Chem; 2006 Nov; 281(47):35975-82. PubMed ID: 16998238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb.
    Schmidt K; Hughes C; Chudek JA; Goodyear SR; Aspden RM; Talbot R; Gundersen TE; Blomhoff R; Henderson C; Wolf CR; Tickle C
    Mol Cell Biol; 2009 May; 29(10):2716-29. PubMed ID: 19273610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics of human P450 oxidoreductase.
    Pandey AV; Sproll P
    Front Pharmacol; 2014; 5():103. PubMed ID: 24847272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and biochemical consequences of p450 oxidoreductase deficiency.
    Flück CE; Pandey AV
    Endocr Dev; 2011; 20():63-79. PubMed ID: 21164260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing : Overall analysis of a female with POR deficiency.
    Zhang T; Li Z; Ren X; Huang B; Zhu G; Yang W; Jin L
    J Assist Reprod Genet; 2020 Oct; 37(10):2503-2511. PubMed ID: 32725309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.
    Kranendonk M; Marohnic CC; Panda SP; Duarte MP; Oliveira JS; Masters BS; Rueff J
    Arch Biochem Biophys; 2008 Jul; 475(2):93-9. PubMed ID: 18455494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P450 Oxidoreductase Deficiency: Loss of Activity Caused by Protein Instability From a Novel L374H Mutation.
    Parween S; Roucher-Boulez F; Flück CE; Lienhardt-Roussie A; Mallet D; Morel Y; Pandey AV
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4789-4798. PubMed ID: 27603900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human
    Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
    J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia.
    Flück CE; Miller WL
    Curr Opin Pediatr; 2006 Aug; 18(4):435-41. PubMed ID: 16915000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients.
    Fukami M; Horikawa R; Nagai T; Tanaka T; Naiki Y; Sato N; Okuyama T; Nakai H; Soneda S; Tachibana K; Matsuo N; Sato S; Homma K; Nishimura G; Hasegawa T; Ogata T
    J Clin Endocrinol Metab; 2005 Jan; 90(1):414-26. PubMed ID: 15483095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.
    Flück CE; Tajima T; Pandey AV; Arlt W; Okuhara K; Verge CF; Jabs EW; Mendonça BB; Fujieda K; Miller WL
    Nat Genet; 2004 Mar; 36(3):228-30. PubMed ID: 14758361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minireview: regulation of steroidogenesis by electron transfer.
    Miller WL
    Endocrinology; 2005 Jun; 146(6):2544-50. PubMed ID: 15774560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase.
    Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):64-70. PubMed ID: 27032764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of Antley-Bixler syndrome caused by novel POR mutations].
    Peng C; Huang C; Tan H; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):1025-1027. PubMed ID: 31598952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.